Inhibition of GCN2 Alleviates Cardiomyopathy in Type 2 Diabetic Mice via Attenuating Lipotoxicity and Oxidative Stress
Diabetic cardiomyopathy (DCM) is a kind of heart disease that affects diabetic patients and is one of the primary causes of death. We previously demonstrated that deletion of the general control nonderepressible 2 (GCN2) kinase ameliorates cardiac dysfunction in diabetic mice. The aim of this study...
Saved in:
Main Authors: | Juntao Yuan (Author), Fang Li (Author), Bingqing Cui (Author), Junling Gao (Author), Zhuoran Yu (Author), Zhongbing Lu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic and Pharmacological Inhibition of GCN2 Ameliorates Hyperglycemia and Insulin Resistance in Type 2 Diabetic Mice
by: Juntao Yuan, et al.
Published: (2022) -
Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice: Involvement of reduced S100A11 expression
by: Xiyue Shen, et al.
Published: (2023) -
Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy
by: Michinari Nakamura
Published: (2024) -
DDAH1 Protects against Acetaminophen-Induced Liver Hepatoxicity in Mice
by: Xiyue Shen, et al.
Published: (2022) -
Enhancing Fatty Acids Oxidation via L-Carnitine Attenuates Obesity-Related Atrial Fibrillation and Structural Remodeling by Activating AMPK Signaling and Alleviating Cardiac Lipotoxicity
by: Yudi Zhang, et al.
Published: (2021)